135 related articles for article (PubMed ID: 36716490)
41. FDG PET-CT evaluation in neurolymphomatosis: imaging characteristics and clinical outcomes.
Davidson T; Kedmi M; Avigdor A; Komisar O; Chikman B; Lidar M; Goshen E; Tzila Zwas S; Ben-Haim S
Leuk Lymphoma; 2018 Feb; 59(2):348-356. PubMed ID: 28750592
[TBL] [Abstract][Full Text] [Related]
42. PET-CT imaging of combined brachial and lumbosacral neurolymphomatosis.
Kanter P; Zeidman A; Streifler J; Marmelstein V; Even-Sapir E; Metser U; Stein GY; Cohen AM
Eur J Haematol; 2005 Jan; 74(1):66-9. PubMed ID: 15613109
[TBL] [Abstract][Full Text] [Related]
43. High-grade B-cell lymphoma relapse presenting as neurolymphomatosis of the median nerve.
Tai R; Maingard J; Nambiar M; Lim K
BMJ Case Rep; 2019 Mar; 12(3):. PubMed ID: 30846458
[TBL] [Abstract][Full Text] [Related]
44. Neurolymphomatosis--diagnosis and assessment of treatment response by FDG PET-CT.
Lin M; Kilanowska J; Taper J; Chu J
Hematol Oncol; 2008 Mar; 26(1):43-5. PubMed ID: 17957824
[TBL] [Abstract][Full Text] [Related]
45. 2-[18F]FDG-PET/CT for early response and brain metabolic pattern assessment after CAR-T cell therapy in a diffuse large B cell lymphoma patient with ICANS.
Paccagnella A; Farolfi A; Casadei B; Garibotto V; Zinzani P; Fanti S
Eur J Nucl Med Mol Imaging; 2022 Feb; 49(3):1090-1091. PubMed ID: 34550427
[No Abstract] [Full Text] [Related]
46. Neurolymphomatosis: a single-center experience of neuromuscular manifestations, treatments, and outcomes.
Jeong J; Kim SW; Sung DH
J Neurol; 2021 Mar; 268(3):851-859. PubMed ID: 33098033
[TBL] [Abstract][Full Text] [Related]
47. Bilateral primary renal lymphoma in a pediatric patient: staging and response evaluation with ¹⁸F-FDG PET/CT.
Dhull VS; Mukherjee A; Karunanithi S; Durgapal P; Bal C; Kumar R
Rev Esp Med Nucl Imagen Mol; 2015; 34(1):49-52. PubMed ID: 25065972
[TBL] [Abstract][Full Text] [Related]
48. Increased Prostate Cancer Glucose Metabolism Detected by
Lavallée E; Bergeron M; Buteau FA; Blouin AC; Duchesnay N; Dujardin T; Tiguert R; Lacombe L; Fradet V; Makao-Nguile M; Fradet Y; Beauregard JM; Pouliot F
Eur Urol Focus; 2019 Nov; 5(6):998-1006. PubMed ID: 29609897
[TBL] [Abstract][Full Text] [Related]
49. Prognostic Importance of Bone Marrow Uptake on Baseline
Soydal C; Koksoy EB; Yasar A; Turgal E; Erdogan BD; Akbulut H; Kucuk NO
Cancer Biother Radiopharm; 2016 Dec; 31(10):361-365. PubMed ID: 27996313
[TBL] [Abstract][Full Text] [Related]
50. Sacral nerve root neurolymphomatosis diagnosed on FDG-PET/CT and magnetic resonance imaging.
Dong Q; Wong KK; Avram AM
Clin Nucl Med; 2008 Jan; 33(1):30-1. PubMed ID: 18097253
[TBL] [Abstract][Full Text] [Related]
51. Diagnostic value of integrated ¹⁸F-fluoro-2-deoxyglucose positron emission tomography/computed tomography in recurrent epithelial ovarian cancer: accuracy of patient selection for secondary cytoreduction in 134 patients.
Lee YJ; Kim YM; Jung PS; Lee JJ; Kim JK; Kim YT; Nam JH
J Gynecol Oncol; 2018 May; 29(3):e36. PubMed ID: 29400023
[TBL] [Abstract][Full Text] [Related]
52. [A case of neurolymphomatosis diagnosed with FDG-PET].
Hoshikawa Y; Oguri T; Hattori M; Uematsu N; Matsukawa N; Yamawaki T; Kusumoto S; Ojika K
Rinsho Shinkeigaku; 2007 Jul; 47(7):437-40. PubMed ID: 17710889
[TBL] [Abstract][Full Text] [Related]
53. Development of a radiomic-clinical nomogram for prediction of survival in patients with diffuse large B-cell lymphoma treated with chimeric antigen receptor T cells.
Zhou Y; Zhang B; Han J; Dai N; Jia T; Huang H; Deng S; Sang S
J Cancer Res Clin Oncol; 2023 Oct; 149(13):11549-11560. PubMed ID: 37395846
[TBL] [Abstract][Full Text] [Related]
54. Early 18F-FDG PET Flare-up Phenomenon After CAR T-Cell Therapy in Lymphoma.
Boursier C; Perrin M; Bordonne M; Campidelli A; Verger A
Clin Nucl Med; 2022 Feb; 47(2):e152-e153. PubMed ID: 34406181
[TBL] [Abstract][Full Text] [Related]
55. Prognostic value of
Sun N; Qiao W; Xing Y; Wang T; Yang J; Zhao J
Clin Transl Oncol; 2021 Aug; 23(8):1571-1576. PubMed ID: 33449269
[TBL] [Abstract][Full Text] [Related]
56. [Neurolymphomatosis Mimicking Inflammatory Neuropathy with Slight FDG Uptake on PET/CT and Distinct MRI Abnormalities in the Brachial Plexus: A Case Report].
Shima T; Tsujino A
Brain Nerve; 2020 Sep; 72(9):987-992. PubMed ID: 32934188
[TBL] [Abstract][Full Text] [Related]
57. Prognostic value of FDG-PET/CT response for patient selection before chimeric antigen receptor-T-cells therapy in non-Hodgkin lymphoma.
Bailly C; Carlier T; Tessoulin B; Gastinne T; Kraeber-Bodere F; Le Gouill S; Bodet-Milin C
Hematol Oncol; 2022 Oct; 40(4):796-800. PubMed ID: 35044695
[No Abstract] [Full Text] [Related]
58. Early evaluation of tumor response to
Kitajima K; Okada M; Kashiwagi T; Yoshihara K; Tokugawa T; Sawada A; Yoshihara S; Fujimori Y; Yamakado K
Eur Radiol; 2019 Jul; 29(7):3935-3944. PubMed ID: 30899979
[TBL] [Abstract][Full Text] [Related]
59. Primary neurolymphomatosis diagnosed by spinal nerve root biopsy.
Saunders SL; Giang SM; Sriweerawanidchakun S; Schutz A
Pract Neurol; 2024 May; 24(3):231-234. PubMed ID: 38388433
[TBL] [Abstract][Full Text] [Related]
60. A rare case of primary intraosseous carcinoma of the mandible with perineural extension mimicking neurolymphomatosis on [
Yokoyama K; Tsuchiya J; Kawabe H; Asakage T; Tateishi U
Eur J Nucl Med Mol Imaging; 2023 May; 50(6):1835-1836. PubMed ID: 36522436
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
